Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

0(0%)

Results Posted

25%(1 trials)

Phase Distribution

Ph phase_3

17%

Ph not_applicable

83%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 3Large-scale testing

1(16.7%)

N/ANon-phased studies

5(83.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(4)

Other(2)

Detailed Status

Completed4

unknown2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 31 (16.7%)

N/A5 (83.3%)

Trials by Status

completed467%

unknown233%

Recent Activity

0 active trials

Showing 5 of 6

completednot_applicable

Evaluate the Effect of Diet on Gastrointestinal Adverse Events in Patients With IPF Treated With Pirfenidone

NCT03539289

completednot_applicable

Clinical Trials (6)

Showing 6 of 6 trials

NCT03539289Not Applicable

Evaluate the Effect of Diet on Gastrointestinal Adverse Events in Patients With IPF Treated With Pirfenidone

Completed

NCT03380416Not Applicable

Effects of a Portfolio Diet on NAFLD in Type 2 Diabetic Patients

Completed

NCT02757560Not Applicable

Dietary Lipid Induced Insulin Resistance

Unknown

NCT02106208Not Applicable

Study of the Impact of Dairy Fat on Cardiovascular Health.

Completed

NCT01478958Not Applicable

Dietary Intervention and Vascular Function

Completed

NCT00520182Phase 3

Dietary Interventions in Type 2 Obese Diabetic Patients in the Community

Unknown

All 6 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 6